Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes: Anti-CGRP ligand monoclonal antibody & routes: Subcutaneous & halflife: ~27 days

Use the filters below to narrow your results.

generic:
None (1)
brand:
Emgality (1)
classes: (Click arrow to add another value)
mechanism:
Humanized IgG4 monoclonal antibody binding CGRP peptide; prevents CGRP from activating its receptor (1)
uses:
Preventive treatment of migraine in adults; episodic cluster headache (1)
starting dose:
Migraine: 240 mg SC loading dose, then 120 mg SC monthly. Cluster: 300 mg SC at onset of cluster period, then monthly during cluster. (1)
preparations:
120 mg/mL prefilled syringe or autoinjector (1)
fda max:
240 mg loading + 120 mg/month for migraine; 300 mg/month for cluster (1)
routes: (Click arrow to add another value)
onset:
Over weeks (1)
duration:
Monthly dosing (1)
halflife: (Click arrow to add another value)
bioavailability:
Not formally established (high SC) (1)
pregnancy:
Limited data; avoid (1)
legal:
Rx (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"